CA2416054A1 - Process for folding chemically synthesized polypeptides - Google Patents
Process for folding chemically synthesized polypeptides Download PDFInfo
- Publication number
- CA2416054A1 CA2416054A1 CA002416054A CA2416054A CA2416054A1 CA 2416054 A1 CA2416054 A1 CA 2416054A1 CA 002416054 A CA002416054 A CA 002416054A CA 2416054 A CA2416054 A CA 2416054A CA 2416054 A1 CA2416054 A1 CA 2416054A1
- Authority
- CA
- Canada
- Prior art keywords
- cysteine
- folding
- polypeptide
- temperature
- folding buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00204207 | 2000-11-27 | ||
EP00204207.5 | 2000-11-27 | ||
PCT/EP2001/014163 WO2002050099A2 (en) | 2000-11-27 | 2001-11-27 | Process for folding chemically synthesized polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2416054A1 true CA2416054A1 (en) | 2002-06-27 |
Family
ID=8172340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002416054A Abandoned CA2416054A1 (en) | 2000-11-27 | 2001-11-27 | Process for folding chemically synthesized polypeptides |
Country Status (22)
Country | Link |
---|---|
US (2) | US20020082384A1 (pt) |
EP (2) | EP1679318A1 (pt) |
JP (1) | JP2004516300A (pt) |
KR (1) | KR20030081315A (pt) |
CN (2) | CN1249078C (pt) |
AT (1) | ATE322501T1 (pt) |
AU (2) | AU2002229603B2 (pt) |
BR (1) | BR0113091A (pt) |
CA (1) | CA2416054A1 (pt) |
CU (1) | CU23034A3 (pt) |
DE (1) | DE60118598T2 (pt) |
DK (1) | DK1337549T3 (pt) |
ES (1) | ES2261509T4 (pt) |
HU (1) | HUP0302395A3 (pt) |
IL (1) | IL155506A0 (pt) |
MX (1) | MXPA03003576A (pt) |
NO (1) | NO20032356D0 (pt) |
NZ (1) | NZ523679A (pt) |
PL (1) | PL364932A1 (pt) |
RU (1) | RU2275377C2 (pt) |
WO (1) | WO2002050099A2 (pt) |
ZA (1) | ZA200300642B (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091310B2 (en) * | 2002-09-13 | 2006-08-15 | Chemokine Therapeutics Corporation | Chemokine analogs for the treatment of human disease |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
EP1615945B1 (en) | 2003-04-09 | 2011-09-28 | BioGeneriX AG | Glycopegylation methods and proteins/peptides produced by the methods |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
EP1807442A1 (en) * | 2004-10-26 | 2007-07-18 | Lonza Ag | S-alkyl-sulphenyl protection groups in solid-phase synthesis |
US20080176790A1 (en) | 2004-10-29 | 2008-07-24 | Defrees Shawn | Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf) |
US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
EP1893632B1 (en) * | 2005-06-17 | 2015-08-12 | Novo Nordisk Health Care AG | Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
US20090081145A1 (en) * | 2005-12-23 | 2009-03-26 | Aplagen Gmbh | Process for forming disulphide bridges |
AU2007248855A1 (en) * | 2006-05-03 | 2007-11-15 | Mallinckrodt Inc. | Composition and method for the release of protected peptides from a resin |
US20080242607A1 (en) | 2006-07-21 | 2008-10-02 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
US20100075375A1 (en) | 2006-10-03 | 2010-03-25 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
WO2008077621A1 (de) * | 2006-12-23 | 2008-07-03 | Aplagen Gmbh | Verfahren zur ausbildung von disulfidbrücken |
KR20100016160A (ko) | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 g―csf를 이용하는 치료 방법 |
MX2009013259A (es) | 2007-06-12 | 2010-01-25 | Novo Nordisk As | Proceso mejorado para la produccion de azucares de nucleotidos. |
US20130189239A1 (en) | 2008-02-27 | 2013-07-25 | Novo Nordisk A/S | Conjugated Factor VIII Molecules |
CN104844693B (zh) * | 2015-06-10 | 2018-08-03 | 成都圣诺生物科技股份有限公司 | 一种合成利那洛肽的方法 |
CN111655314B (zh) | 2018-02-02 | 2022-11-18 | 诺和诺德股份有限公司 | 具有可偏转换能器的药物注射装置 |
CN111100188A (zh) * | 2018-10-25 | 2020-05-05 | 成都医学院 | 一种制备蜘蛛抗菌肽的方法 |
CN109593119A (zh) * | 2019-01-27 | 2019-04-09 | 上海丽珠制药有限公司 | 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法 |
JP7453745B2 (ja) * | 2019-03-28 | 2024-03-21 | 株式会社ヤクルト本社 | 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法 |
CN110845595A (zh) * | 2019-11-14 | 2020-02-28 | 连云港职业技术学院 | 一种固相合成5-tmara标记的铁调素-25的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923787A1 (de) * | 1979-06-12 | 1980-12-18 | Max Planck Gesellschaft | Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel |
DE3236849A1 (de) * | 1982-10-05 | 1984-04-05 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung |
IL96682A0 (en) * | 1989-12-15 | 1991-09-16 | Amgen Inc | Production of biologically active platelet-derived growth factor from high expression host cell systems |
CA2072249C (en) * | 1991-06-28 | 2003-06-17 | Saiko Hosokawa | Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
CN1105029A (zh) * | 1993-05-24 | 1995-07-12 | 花王株式会社 | 制备溶解蛋白质的方法 |
US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
DE4431317A1 (de) * | 1994-09-02 | 1996-03-07 | Biotechnolog Forschung Gmbh | Schutz- bzw. Ankergruppen und deren Verwendung |
-
2001
- 2001-11-27 DK DK01990489T patent/DK1337549T3/da active
- 2001-11-27 KR KR10-2003-7004957A patent/KR20030081315A/ko not_active Application Discontinuation
- 2001-11-27 AU AU2002229603A patent/AU2002229603B2/en not_active Expired - Fee Related
- 2001-11-27 BR BR0113091-9A patent/BR0113091A/pt not_active IP Right Cessation
- 2001-11-27 WO PCT/EP2001/014163 patent/WO2002050099A2/en active IP Right Grant
- 2001-11-27 PL PL01364932A patent/PL364932A1/xx not_active Application Discontinuation
- 2001-11-27 HU HU0302395A patent/HUP0302395A3/hu unknown
- 2001-11-27 DE DE60118598T patent/DE60118598T2/de not_active Expired - Fee Related
- 2001-11-27 JP JP2002551992A patent/JP2004516300A/ja active Pending
- 2001-11-27 NZ NZ523679A patent/NZ523679A/en unknown
- 2001-11-27 CN CNB018147968A patent/CN1249078C/zh not_active Expired - Fee Related
- 2001-11-27 RU RU2003119075/04A patent/RU2275377C2/ru not_active IP Right Cessation
- 2001-11-27 EP EP06075237A patent/EP1679318A1/en not_active Withdrawn
- 2001-11-27 EP EP01990489A patent/EP1337549B1/en not_active Expired - Lifetime
- 2001-11-27 US US09/995,335 patent/US20020082384A1/en not_active Abandoned
- 2001-11-27 AU AU2960302A patent/AU2960302A/xx active Pending
- 2001-11-27 AT AT01990489T patent/ATE322501T1/de not_active IP Right Cessation
- 2001-11-27 CU CU20030094A patent/CU23034A3/es unknown
- 2001-11-27 CA CA002416054A patent/CA2416054A1/en not_active Abandoned
- 2001-11-27 CN CNA2006100047520A patent/CN1830999A/zh active Pending
- 2001-11-27 MX MXPA03003576A patent/MXPA03003576A/es active IP Right Grant
- 2001-11-27 ES ES01990489T patent/ES2261509T4/es not_active Expired - Lifetime
- 2001-11-27 IL IL15550601A patent/IL155506A0/xx unknown
-
2003
- 2003-01-23 ZA ZA200300642A patent/ZA200300642B/en unknown
- 2003-05-26 NO NO20032356A patent/NO20032356D0/no unknown
-
2005
- 2005-05-19 US US11/132,987 patent/US20050239162A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050239162A1 (en) | 2005-10-27 |
ES2261509T4 (es) | 2008-02-16 |
RU2275377C2 (ru) | 2006-04-27 |
CN1249078C (zh) | 2006-04-05 |
ATE322501T1 (de) | 2006-04-15 |
DK1337549T3 (da) | 2006-07-31 |
NO20032356L (no) | 2003-05-26 |
HUP0302395A2 (hu) | 2003-10-28 |
ZA200300642B (en) | 2004-07-16 |
DE60118598D1 (de) | 2006-05-18 |
WO2002050099A2 (en) | 2002-06-27 |
US20020082384A1 (en) | 2002-06-27 |
JP2004516300A (ja) | 2004-06-03 |
DE60118598T2 (de) | 2007-02-15 |
ES2261509T3 (es) | 2006-11-16 |
EP1337549B1 (en) | 2006-04-05 |
NZ523679A (en) | 2005-10-28 |
KR20030081315A (ko) | 2003-10-17 |
BR0113091A (pt) | 2003-07-08 |
CN1449406A (zh) | 2003-10-15 |
MXPA03003576A (es) | 2003-10-14 |
HUP0302395A3 (en) | 2007-05-02 |
AU2002229603B2 (en) | 2007-11-08 |
EP1337549A2 (en) | 2003-08-27 |
AU2960302A (en) | 2002-07-01 |
NO20032356D0 (no) | 2003-05-26 |
CN1830999A (zh) | 2006-09-13 |
PL364932A1 (en) | 2004-12-27 |
EP1679318A1 (en) | 2006-07-12 |
IL155506A0 (en) | 2003-11-23 |
WO2002050099A3 (en) | 2002-09-19 |
CU23034A3 (es) | 2005-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1337549B1 (en) | Process for folding chemically synthesized polypeptides | |
CN111670194B (zh) | 制备胰高血糖素肽 | |
JP5328345B2 (ja) | ペプチドのチオエステル化合物の製造方法 | |
EP2486045B1 (en) | Insulin like peptides | |
RU2755543C2 (ru) | Способ получения пептидов, содержащих липофильно модифицированную боковую цепь лизина | |
US9309278B2 (en) | Method for modification of organic molecules | |
AU700605B2 (en) | Production of peptides using recombinant fusion protein constructs | |
Castellanos-Serra et al. | Expression and folding of an interleukin‐2‐proinsulin fusion protein and its conversion into insulin by a single step enzymatic removal of the C‐peptide and the N‐terminal fused sequence | |
US7659363B2 (en) | Process for the preparation of insulin or an insulin derivative in the presence of oxygen | |
US20220033440A1 (en) | An improved process for the preparation of plecanatide | |
AU719029B2 (en) | Preparation of purified (poly)peptides | |
WO2022044030A1 (en) | An improved process for fmoc synthesis of etelcalcetide | |
EP2314646A1 (en) | Diselenide-resins for oxidative protein folding | |
AU2003214068A1 (en) | Method for producing interferon | |
US20060252917A1 (en) | Methods for refolding conformationally constrained peptides | |
CN115873073A (zh) | 一种普卡那肽的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |